5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). (Q33493381)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). |
scientific article |
Statements
1 reference
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). (English)
1 reference
A Cervantes
1 reference
A Villar-Grimalt
1 reference
A Abad
1 reference
A Antón-Torres
1 reference
J Belón
1 reference
J Dorta
1 reference
A Tres
1 reference
C Camps
1 reference
E Fonseca
1 reference
B Massutí
1 reference
1 November 1993
1 reference
1 reference
753-757
1 reference
Identifiers
1 reference
1 reference